Search results
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 2 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 3 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 2 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 3 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 1 day agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...